Beam Therapeutics Inc. (BEAM) NASDAQ
31.14
-1.79(-5.44%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
31.14
-1.79(-5.44%)
Currency In USD
| Market Cap | 2.74B |
| Enterprise Value | 2.74B |
| P/E Ratio | -49.44 |
| PEG Ratio | -0.33 |
| Price/Sales Ratio | 19.53 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 19.3 |
| Enterprise/EBITDA | -50.43 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.4 |
| Operating Margin | -2.27 |
| Return On Assets | -0.04 |
| Return On Equity | -0.06 |
| Revenue | 139.74M |
| Revenue/Share | 1.59 |
| Gross Profit | 117.45M |
| EBITDA | -29.92M |
| Net Income | -79.99M |
| Diluted EPS | -0.81 |
| Total Cash | 1.21B |
| Total Cash/Share | 11.73 |
| Total Debt | 250.82M |
| Total Debt/Equity | 0.22 |
| Current Ratio | 16.99 |
| Book Value Per Share | 11.28 |
| 52-Week Change | 92.34 |
| 52-Week High | 36.44 |
| 52-Week Low | 15.6 |
| Moving Average 50 Days | 28.44 |
| Moving Average 200 Days | 26.09 |
| Average Volume | 2.08M |
| Shares Outstanding | 102.88M |
| % Held by Institutions | 109.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |